Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.

Saved in:
Bibliographic Details
Title: Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
Authors: Burke BP; Calimmune, Inc., Los Angeles, California, USA., Levin BR; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Zhang J; Calimmune, Inc., Los Angeles, California, USA., Sahakyan A; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Boyer J; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Carroll MV; Calimmune, Inc., Los Angeles, California, USA., Colón JC; Calimmune, Inc., Los Angeles, California, USA., Keech N; Calimmune, Inc., Los Angeles, California, USA., Rezek V; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Bristol G; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Eggers E; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Cortado R; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Boyd MP; Calimmune, Inc., Los Angeles, California, USA., Impey H; Calimmune, Inc., Los Angeles, California, USA., Shimizu S; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Lowe EL; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Ringpis GE; Calimmune, Inc., Los Angeles, California, USA., Kim SG; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Vatakis DN; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Breton LR; Calimmune, Inc., Los Angeles, California, USA., Bartlett JS; Calimmune, Inc., Los Angeles, California, USA., Chen IS; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Kitchen SG; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., An DS; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Symonds GP; Calimmune, Inc., Los Angeles, California, USA.
Source: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2015 Apr 14; Vol. 4, pp. e236. Date of Electronic Publication: 2015 Apr 14.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: Electronic Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-2531
DOI:10.1038/mtna.2015.10